|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Noguti J, De Moura CF, De Jesus GP, Da
Silva VH, Hossaka TA, Oshima CT and Ribeiro DA: Metastasis from
oral cancer: An overview. Cancer Genomics Proteomics. 9:329–335.
2012.PubMed/NCBI
|
|
3
|
Patel SG, Amit M, Yen TC, Liao CT,
Chaturvedi P, Agarwal JP, Kowalski LP, Ebrahimi A, Clark JR, Cernea
CR, et al: Lymph node density in oral cavity cancer: Results of the
International consortium for outcomes research. Br J Cancer.
109:2087–2095. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Warnakulasuriya S: Global epidemiology of
oral and oropharyngeal cancer. Oral Oncol. 45:309–316. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sano D and Myers JN: Metastasis of
squamous cell carcinoma of the oral tongue. Cancer Metastasis Rev.
26:645–662. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Micalizzi DS, Farabaugh SM and Ford HL:
Epithelial-mesenchymal transition in cancer: Parallels between
normal development and tumor progression. J Mammary Gland Biol
Neoplasia. 15:117–134. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Smith A, Teknos TN and Pan Q: Epithelial
to mesenchymal transition in head and neck squamous cell carcinoma.
Oral Oncol. 49:287–292. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zheng H and Kang Y: Multilayer control of
the EMT master regulators. Oncogene. 33:1755–1763. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Oberlin E, Amara A, Bachelerie F, Bessia
C, Virelizier JL, Arenzana-Seisdedos F, Schwartz O, Heard JM,
Clark-Lewis I, Legler DF, et al: The CXC chemokine SDF-1 is the
ligand for LESTR/fusin and prevents infection by
T-cell-line-adapted HIV-1. Nature. 382:833–835. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Murdoch C: CXCR4: Chemokine receptor
extraordinaire. Immunol Rev. 177:175–184. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Teng F, Tian WY, Wang YM, Zhang YF, Guo F,
Zhao J, Gao C and Xue FX: Cancer-associated fibroblasts promote the
progression of endometrial cancer via the SDF-1/CXCR4 axis. J
Hematol Oncol. 9:82016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang DL, Xin MM, Wang JS, Xu HY, Huo Q,
Tang ZR and Wang HF: Chemokine receptor CXCR4 and its ligand CXCL12
expressions and clinical significance in bladder cancer. Genet Mol
Res. 14:17699–17707. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guo Q, Gao BL, Zhang XJ, Liu GC, Xu F, Fan
QY, Zhang SJ, Yang B and Wu XH: CXCL12-CXCR4 axis promotes
proliferation, migration, invasion, and metastasis of ovarian
cancer. Oncol Res. 22:247–258. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu W, Qian L, Chen X and Ding B:
Prognostic significance of CXCL12, CXCR4, and CXCR7 in patients
with breast cancer. Int J Clin Exp Pathol. 8:13217–13224.
2015.PubMed/NCBI
|
|
16
|
Gros SJ, Kurschat N, Drenckhan A, Dohrmann
T, Forberich E, Effenberger K, Reichelt U, Hoffman RM, Pantel K,
Kaifi JT and Izbicki JR: Involvement of CXCR4 chemokine receptor in
metastastic HER2-positive esophageal cancer. PLoS One.
7:e472872012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Müller A, Homey B, Soto H, Ge N, Catron D,
Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, et al:
Involvement of chemokine receptors in breast cancer metastasis.
Nature. 410:50–56. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
An H, Xu L, Zhu Y, Lv T, Liu W, Liu Y, Liu
H, Chen L, Xu J and Lin Z: High CXC chemokine receptor 4 expression
is an adverse prognostic factor in patients with clear-cell renal
cell carcinoma. Br J Cancer. 110:2261–2268. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Scotton CJ, Wilson JL, Scott K, Stamp G,
Wilbanks GD, Fricker S, Bridger G and Balkwill FR: Multiple actions
of the chemokine CXCL12 on epithelial tumor cells in human ovarian
cancer. Cancer Res. 62:5930–5938. 2002.PubMed/NCBI
|
|
20
|
Burger JA and Kipps TJ: CXCR4: A key
receptor in the crosstalk between tumor cells and their
microenvironment. Blood. 107:1761–1767. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Duda DG, Kozin SV, Kirkpatrick ND, Xu L,
Fukumura D and Jain RK: CXCL12 (SDF1alpha)-CXCR4/CXCR7 pathway
inhibition: An emerging sensitizer for anticancer therapies? Clin
Cancer Res. 17:2074–2080. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang B, Zhang CP, Zhang S and Wang XD:
Epithelial-mesenchymal transformation-mediated lymph node
metastasis of oral squamous cell carcinoma and its mechanism.
Chinese Journal of Clinical Oncology. 39:1877–1880. 2012.
|
|
23
|
Rossi D and Zlotnik A: The biology of
chemokines and their receptors. Annu Rev Immunol. 18:217–242. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Perissinotto E, Cavalloni G, Leone F,
Fonsato V, Mitola S, Grignani G, Surrenti N, Sangiolo D, Bussolino
F, Piacibello W and Aglietta M: Involvement of chemokine receptor
4/stromal cell-derived factor 1 system during osteosarcoma tumor
progression. Clin Cancer Res. 11:490–497. 2005.PubMed/NCBI
|
|
25
|
Almofti A, Uchida D, Begum NM, Tomizuka Y,
Iga H, Yoshida H and Sato M: The clinicopathological significance
of the expression of CXCR4 protein in oral squamous cell carcinoma.
Int J Oncol. 25:65–71. 2004.PubMed/NCBI
|
|
26
|
Uchida D, Begum NM, Almofti A, Nakashiro
K, Kawamata H, Tateishi Y, Hamakawa H, Yoshida H and Sato M:
Possible role of stromal-cell-derived factor-1/CXCR4 signaling on
lymph node metastasis of oral squamous cell carcinoma. Exp Cell
Res. 290:289–302. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Uchida D, Onoue T, Kuribayashi N, Tomizuka
Y, Tamatani T, Nagai H and Miyamoto Y: Blockade of CXCR4 in oral
squamous cell carcinoma inhibits lymph node metastases. Eur J
Cancer. 47:452–459. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang SS, Han ZP, Jing YY, Tao SF, Li TJ,
Wang H, Wang Y, Li R, Yang Y, Zhao X, et al: CD133(+) CXCR4(+)
colon cancer cells exhibit metastatic potential and predict poor
prognosis of patients. BMC Med. 10:852012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li X, Li P, Chang Y, Xu Q, Wu Z, Ma Q and
Wang Z: The SDF-1/CXCR4 axis induces epithelial-mesenchymal
transition in hepatocellular carcinoma. Mol Cell Biochem.
392:77–84. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhu Y, Yang P, Wang Q, Hu J, Xue J, Li G,
Zhang G, Li X, Li W, Zhou C, et al: The effect of CXCR4 silencing
on epithelial-mesenchymal transition related genes in glioma U87
cells. Anat Rec (Hoboken). 296:1850–1856. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li X, Ma Q, Xu Q, Liu H, Lei J, Duan W,
Bhat K, Wang F, Wu E and Wang Z: SDF-1/CXCR4 signaling induces
pancreatic cancer cell invasion and epithelial-mesenchymal
transition in vitro through non-canonical activation of Hedgehog
pathway. Cancer Lett. 322:169–176. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Thomas RM, Kim J, Revelo-Penafiel MP,
Angel R, Dawson DW and Lowy AM: The chemokine receptor CXCR4 is
expressed in pancreatic intraepithelial neoplasia. Gut.
57:1555–1560. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yu T, Wu Y, Huang Y, Yan C, Liu Y, Wang Z,
Wang X, Wen Y, Wang C and Li L: RNAi targeting CXCR4 inhibits tumor
growth through inducing cell cycle arrest and apoptosis. Mol Ther.
20:398–407. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Valdés F, Alvarez AM, Locascio A, Vega S,
Herrera B, Fernández M, Benito M, Nieto MA and Fabregat I: The
epithelial mesenchymal transition confers resistance to the
apoptotic effects of transforming growth factor Beta in fetal rat
hepatocytes. Mol Cancer Res. 1:68–78. 2002.PubMed/NCBI
|
|
35
|
Robson EJ, Khaled WT, Abell K and Watson
CJ: Epithelial-to-mesenchymal transition confers resistance to
apoptosis in three murine mammary epithelial cell lines.
Differentiation. 74:254–264. 2006. View Article : Google Scholar : PubMed/NCBI
|
